28A-1120529
Patent pending
This convenient assay is good for new antibiotic drug discovery through targeting PGN, and its related molecules, or lipid II as a goal. The potential applications are listed below:
1. Rapid and initial PGN binder screening
2. Initial antibiotic drug discovery
3. Microbe-host interaction assay platform and related immune response modulation.
4. Binding assay platform/method applied for interaction studies between candidates and bacterial
peptidoglycan or its bio-substrates or bio-precursors
- The current most rapid analytic method for screening the Lipid II binder.
- The current most complete Lipid II-based analogues as a chemical pool.
- If more hit can be screened, it is useful for bacterial drug-resistant issue.
- Screening for Lipid II binder as antibacterial agent.
- Primary understanding of the structure-activity relationship (SAR) based on Lipid II.
- According to the SAR, the diversity of antibiotics can be design.
Cheng, Wie-Chieh, Lin, Jung-Lee
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Developing a label-free affinity assay to target bacterial peptidoglycan-related biosynthetic substrates